GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singular Health Group Ltd (ASX:SHG) » Definitions » Notes Receivable

Singular Health Group (ASX:SHG) Notes Receivable : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Singular Health Group Notes Receivable?

Singular Health Group's Notes Receivable for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Singular Health Group Notes Receivable Historical Data

The historical data trend for Singular Health Group's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singular Health Group Notes Receivable Chart

Singular Health Group Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Notes Receivable
- - - -

Singular Health Group Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Notes Receivable Get a 7-Day Free Trial - - - - -

Singular Health Group Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Singular Health Group Notes Receivable Related Terms

Thank you for viewing the detailed overview of Singular Health Group's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Singular Health Group Business Description

Traded in Other Exchanges
N/A
Address
2/41 Discovery Drive Bibra, Bibra Lake, WA, AUS, 6163
Singular Health Group Ltd provides medical software solutions. The company's business segment is the provision of Volume Rendering Platform (VRP) software, providing 3D printing services and 3D machine sales. It operates in one segment, which is the provision and development of medical technology within Australia.